ERNIE study
Recruiting
Who can enter
Children who have completed treatment for a brain tumor
Experiencing cognitive difficulties
Age: 8-17 years
Please note that this study requires that children/parents speak Dutch
Goal
The goal of this study is to find out what is more helpful in dealing with the neuropsychological consequences of a brain tumor: an approach that is the same for everyone (standardized), or an approach that is tailored to the child's complaints and goals (personalized). We also want to know about the experiences of children and their parents and the areas of improvement in carrying out this intervention.
Background
Background
Children who have had a brain tumor may develop problems with thinking, behaving and the way they are feeling due to the disease and/or treatment. For example, problems with concentration or feelings of sadness or anxiety. These are also known as neuropsychological problems. In the ERNIE study we want to see how we can reduce the influence of these problems on daily life, for example at school, at home or with friends. We want to know whether the treatment works better if it is personalized, instead of a standardized treatment that is the same for everyone.
The ERNIE treatment consists of six sessions and covers various topics, such as:
What is a brain tumor and what are the neuropsychological consequences
Setting goals to work on
Tips for dealing with those consequences and achieving your goals
During the study, children also get two neuropsychological assessments and children and their parents are requested to complete questionnaires via the KLIK portal.
In order to participate in a study please refer to your/your child’s doctor.
Last reviewed
March 20, 2026
Study details
- Study details
Official title
Evaluating Response to Individualized Neuropsychological Intervention for Children with Brain TumorsCancer type
Brain tumorsMaximum number of patients
144 in the NetherlandsStart date
October 17, 2024Status
OpenLocal principal investigator
Dr. Marita PartanenSponsor
Princess Máxima Center for pediatric oncologyApproval
The study of this new treatment has been reviewed by an accredited medical research ethics committee. This committee has decided that it is justified to ask patients to participate in this study. More information can be found at: CCMO.Trial registry number
Registry ISRCTN: ISRCTN30985676
The above information is intended as a brief summary only and may not reflect the most up-to-date information. For full details and the current status of a protocol, physicians can contact the Princess Máxima Center directly.